BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2576516)

  • 1. [Interaction of rilmenidine with renal imidazoline-guanidine sites].
    Lachaud V; Bidet M; Coupry I; Podevin RA; Poujeol P; Parini A
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():15-8. PubMed ID: 2576516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selectivity of alpha 2-adrenergic agonists for the imidazoline-guanidine and alpha 2-adrenergic receptors].
    Lachaud V; Coupry I; Podevin RA; Koenig E; Parini A
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1135-7. PubMed ID: 2573323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different affinities of alpha 2-agonists for imidazoline and alpha 2-adrenergic receptors.
    Coupry I; Lachaud V; Podevin RA; Koenig E; Parini A
    Am J Hypertens; 1989 Jun; 2(6 Pt 1):468-70. PubMed ID: 2569318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.
    Lachaud-Pettiti V; Podevin RA; Chrétien Y; Parini A
    Eur J Pharmacol; 1991 Jan; 206(1):23-31. PubMed ID: 1648494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of imidazoline-guanidinium receptive sites in renal medulla from human kidney.
    Lachaud V; Limon I; Tesson F; Coupry I; Parini A
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):69S-71S. PubMed ID: 1350730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of nonadrenergic [3H]rilmenidine binding in rat brain and kidney.
    King PR; Suzuki S; Louis WJ; Gundlach AL
    Ann N Y Acad Sci; 1995 Jul; 763():194-207. PubMed ID: 7677331
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
    Evans RG; Haynes JM
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of imidazolines on Na+ transport and intracellular pH in renal proximal tubule cells.
    Bidet M; Poujeol P; Parini A
    Biochim Biophys Acta; 1990 May; 1024(1):173-8. PubMed ID: 2337612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.
    Evans RG; Anderson WP
    Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor.
    Parini A; Coupry I; Graham RM; Uzielli I; Atlas D; Lanier SM
    J Biol Chem; 1989 Jul; 264(20):11874-8. PubMed ID: 2545687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of imidazoline sites in rabbit kidney.
    Hamilton CA; Jardine E; Reid JL
    Eur J Pharmacol; 1993 Oct; 243(1):95-7. PubMed ID: 7902815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptors.
    Harron DW
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):91S-98S. PubMed ID: 1350732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of clonidine and rilmenidine with imidazoline-preferring receptors.
    Lachaud V; Coupry I; Podevin RA; Dausse JP; Koenig E; Parini A
    J Hypertens Suppl; 1988 Dec; 6(4):S511-3. PubMed ID: 3241245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
    Sannajust F; Head GA
    Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selectivity of a new antihypertensive agent, rilmenidine, for imidazoline receptors in the human brain].
    Bricca G; Dontenwill M; Feldman J; Belcourt A; Bousquet P
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1325-8. PubMed ID: 1979731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
    Chan CK; Burke SL; Head GA
    J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
    King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.